公司簡介：
惠恒醫(yī)療是一家美國上市的中國民營企業(yè)（HHGM.OB），專業(yè)從事大型放射醫(yī)療設(shè)備研發(fā)、生產(chǎn)、銷售和服務(wù)。
深圳奧沃國際科技發(fā)展有限公司為惠恒醫(yī)療在中國大陸設(shè)立的子公司，同時(shí)惠恒醫(yī)療在中國境內(nèi)還擁有三家控股子公司，分別為：深圳海博科技有限公司（以下簡稱海博公司）、武漢康橋醫(yī)學(xué)新技術(shù)有限公司（以下簡稱康橋公司）和北京原康科貝特核技術(shù)有限公司（以下簡稱原康公司）。其中，海博公司和康橋公司先后被當(dāng)?shù)卣袨楦呖萍计髽I(yè)。
惠恒醫(yī)療公司在中國已擁有了多項(xiàng)產(chǎn)品專利并且在美國和歐洲申請(qǐng)了多項(xiàng)產(chǎn)品專利，公司曾推出世界上首臺(tái)可以治療頭部和體部腫瘤的全身伽馬射線治療系統(tǒng)（SGS），公司還推出了多葉準(zhǔn)直器（MLC）、直線加速器（LINAC）和乳腺活檢系統(tǒng)（BLES）,目前已進(jìn)入臨床階段。
惠恒醫(yī)療匯聚大批行業(yè)領(lǐng)域的資深專家，并擁有一個(gè)博士后工作站，同時(shí)公司不斷銳意進(jìn)取，加大研發(fā)力度，積極開拓海外市場，良好的行業(yè)地位以及優(yōu)秀的公司文化正在吸引大批專業(yè)技術(shù)人員的加盟。
Huiheng Medical is a Chinese private enterprise listed in the US. Its ticker symbol is: HHGM.OB. Huiheng specializes in the research, development, production, sales and servicing of large-scale radiotherapy equipment. Huiheng Medical consists of 3 subsidiary holding companies-Shenzhen Hyper Technology Inc. (“Shenzhen Hyper”), Wuhan Kangqiao New Medical Technology Co., Ltd.(“Wuhan Kangqiao”), and Beijing Yuankang Kbeta Nuclear Technology Co., Ltd.(“Beijing Kbeta”). Shenzhen Hyper and Wuhan Kangqiao have received special approvals as Hi-tech enterprises by their local goverments.
The company holds many Chinese patents, also U.S. and EU patents. It introduced the first Whole-body Stereotactic Gamma-ray Treatment System(Super Gamma System-SGS) in the world, a system which treats both head and body tumors.
Huiheng Medical has established itself as the leading brand in China’s radiotherapy industry, and has built a comprehensive sales network covering all China. Because of this and its highly professional corporate culture it has attracted top technical talents to join it, including experienced experts in the field of gamma ray technology. Additionally it owns a post-doctoral workstation.
聯(lián)系方式：
地址：中國廣東深圳市南山區(qū)科苑南路高新南七道惠恒大樓
郵編：518057
電話：86-755-25331366
傳真：86-755-26745291
網(wǎng)址：www.huihengmedical.com